Skip to main content
OpenTrials
Completed

NCT Number: NCT00744120

Lymphoma Follow-up

This follow-up protocol is designed to evaluate participants who have previously been lymphoma patients treated on approved clinical studies of the National Institutes of Health.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

NIA Clinical Research Unit

Baltimore, Maryland, 21225, United States

About this study

The intent of this protocol is to accrue up to 800 volunteers who are interested in participating in NIA research studies as part of follow-up for previous cancer treatment at NIH. Participants will be asked to answer questions regarding their general health status, diagnoses, and admissions to hospital, and to provide possible documentation. They may be asked to come to the NIA Clinical Research Unit at Harbor Hospital to participate in a follow-up evaluation. They will have the opportunity to obtain additional information about studies in which they may wish to participate and to discuss eligibility issues with NIA staff members. Any identified clinical problems in need of care will also be discussed. Volunteers may be referred, with their permission, to their private medical doctor for follow-up. They may be re-evaluated within a year for further follow-up.

The follow-up evaluation may include history and physical, blood and urine tests, questionnaire, MRI or CT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Previously treated on an approved NCI/NIH protocols
  • Willing and able to provide informed consent for current NIA protocol
  • Rare, unusual, interesting or unknown condition that requires diagnosis

Exclusion criteria

  • Does not meet the criteria of any previously-approved NIH Protocol.

Treatment and study plan

Primary outcomes

  1. Long-term survival following treatment for lymphoma

    Time frame: Annually

Secondary outcomes

  1. Long-term toxicity possibly attributable to lymphoma or treatment for lymphoma

    Time frame: Annually

Sponsors and collaborators

Lead sponsor

National Institute on Aging (NIA)

Nih

Registry information

Official study title

Lymphoma Follow-up Protocol

Important dates

Study start
2003
Primary completion
2013
Study completion
2013
First posted
Aug 29, 2008
Registry last updated
Dec 20, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.